Skip to main content
. Author manuscript; available in PMC: 2014 Oct 13.
Published in final edited form as: Clin Cancer Res. 2008 Nov 15;14(22):7196–7204. doi: 10.1158/1078-0432.CCR-07-5051

Fig. 1.

Fig. 1

EPOR expression in ectopic ETV6/RUNX1 transfectants and leukemic cell lines. Quantification of EPOR mRNA expression by real-time quantitative PCR. A, EPOR expression in ectopically ETV6/RUNX1 (E/R)-expressing HEK 293 and Ba/F3 cells. B, EPOR expression in ETV6/RUNX1-positive (REH, AT-1, and AT-2) and ETV6/RUNX1-negative (SEM, Nalm6, Jurkat, and K562) leukemic cell lines. EPOR mRNA levels were determined at least in triplicates and normalized to either HPRT in Ba/F3 cells or h2-microglobulin expression in the remaining cell lines.The n-fold expression was calculated from ETV6/RUNX1-expressing cells relative to control vector-containing cells in A or to Jurkat cells in B. Bars, SD. *, P < 0.01.